Cala, Maclean Health Partner to Expand Veteran Access for Cala kIQ Plus System
SAN MATEO, California—Cala, the bioelectronic medicine producer, announced the availability of the Cala kIQ Plus System, the latest advancement of its wearable neurostimulation device for action hand tremor in essential tremor and Parkinson’s disease, for eligible veterans through its partnership with Maclean Health, a certified service-disabled veteran-owned small business (SDVOSB). The Cala kIQ Plus System, which features the most advanced TAPS therapy, is available to Veterans Affairs (VA) medical centers nationwide on the Federal Supply Schedule (FSS).
Cleared by the FDA earlier this year, the Cala kIQ Plus is a wearable for hand tremors that offers multiple stimulation waveform modes, which users can choose and change at any time along with adaptive calibration to personalize therapy.
“On Veterans Day, we honor those who have served our country, and we are proud to partner with Maclean Health, a veteran-owned healthcare solutions distributor on the Federal Supply Schedule, to bring our most advanced Cala TAPS technology, the Cala kIQ Plus System, to veterans living with hand tremor,” said Cala CEO Deanna Harshbarger. “Cala TAPS therapy is a clinically validated and effective option for veterans, and this partnership will continue to expand access for VA providers to help veterans experiencing tremor.”
Essential tremor (ET) affects an estimated 7 million Americans, and action hand tremor from Parkinson’s disease (PD) adds more to the population living with a condition that disrupts basic daily activities like eating, drinking, dressing and self-care—often with downstream effects on mental health and social participation. Historically, treatment options have been limited to medications that are not tremor-specific and carry side effects or invasive interventions. Many patients discontinue medications due to lack of efficacy or intolerable side effects. Cala TAPS therapy fills that treatment gap with a clinically proven, effective non-invasive wearable with long term real-world evidence spanning over three years.
“Maclean Health is committed to delivering high quality, innovative healthcare products to the VA and the veterans it serves,” said Rear Admiral (ret.) Louis Tripoli, chief medical officer of Maclean Health. “We know the options for patients with hand tremor are limited, have poor side effects or are invasive. The Cala kIQ Plus is a valuable noninvasive option to provide for those we serve.”
The Cala kIQ Plus device is available through the VA Health System at no cost to eligible beneficiaries, with a prescription from a VA healthcare provider. Maclean Health exclusively distributes Cala products to VA medical centers across the United States and has added them to its contracts on the Federal Supply Schedule (FSS 65 II A). Inquiries related to FSS purchasing and order processing should be directed to Maclean Health at [email protected] or (800) 683-4923. Contact Cala at [email protected] or (888) 699-1009.
Post navigation
OUR DIGITAL PARTNERS


